JP2022538789A5 - - Google Patents

Info

Publication number
JP2022538789A5
JP2022538789A5 JP2021573843A JP2021573843A JP2022538789A5 JP 2022538789 A5 JP2022538789 A5 JP 2022538789A5 JP 2021573843 A JP2021573843 A JP 2021573843A JP 2021573843 A JP2021573843 A JP 2021573843A JP 2022538789 A5 JP2022538789 A5 JP 2022538789A5
Authority
JP
Japan
Application number
JP2021573843A
Other languages
Japanese (ja)
Other versions
JPWO2020252378A5 (https=
JP2022538789A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/037585 external-priority patent/WO2020252378A1/en
Publication of JP2022538789A publication Critical patent/JP2022538789A/ja
Publication of JPWO2020252378A5 publication Critical patent/JPWO2020252378A5/ja
Publication of JP2022538789A5 publication Critical patent/JP2022538789A5/ja
Pending legal-status Critical Current

Links

JP2021573843A 2019-06-14 2020-06-12 新規crispr dnaターゲティング酵素及びシステム Pending JP2022538789A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962861582P 2019-06-14 2019-06-14
US62/861,582 2019-06-14
US201962872157P 2019-07-09 2019-07-09
US62/872,157 2019-07-09
US201962873602P 2019-07-12 2019-07-12
US201962873606P 2019-07-12 2019-07-12
US62/873,602 2019-07-12
US62/873,606 2019-07-12
PCT/US2020/037585 WO2020252378A1 (en) 2019-06-14 2020-06-12 Novel crispr dna targeting enzymes and systems

Publications (3)

Publication Number Publication Date
JP2022538789A JP2022538789A (ja) 2022-09-06
JPWO2020252378A5 JPWO2020252378A5 (https=) 2023-06-19
JP2022538789A5 true JP2022538789A5 (https=) 2023-06-19

Family

ID=73781310

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573843A Pending JP2022538789A (ja) 2019-06-14 2020-06-12 新規crispr dnaターゲティング酵素及びシステム

Country Status (7)

Country Link
US (1) US20220315913A1 (https=)
EP (1) EP3983536A4 (https=)
JP (1) JP2022538789A (https=)
CN (1) CN114269912A (https=)
AU (1) AU2020291467A1 (https=)
CA (1) CA3142019A1 (https=)
WO (1) WO2020252378A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220282283A1 (en) * 2019-09-05 2022-09-08 Arbor Biotechnologies, Inc. Novel crispr dna targeting enzymes and systems
US20240093228A1 (en) * 2021-01-22 2024-03-21 Arbor Biotechnologies, Inc. Compositions comprising a nuclease and uses thereof
IL308806A (en) 2021-06-01 2024-01-01 Arbor Biotechnologies Inc Gene editing systems including nuclease crisper and their uses
WO2024173645A1 (en) 2023-02-15 2024-08-22 Arbor Biotechnologies, Inc. Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript
WO2025171210A1 (en) 2024-02-09 2025-08-14 Arbor Biotechnologies, Inc. Compositions and methods for gene editing via homology-mediated end joining
WO2025201481A1 (en) * 2024-03-29 2025-10-02 Yoltech Therapeutics Co., Ltd Crispr-cas systems
WO2026015832A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Reverse transcriptases and gene editing systems comprising such
WO2026015829A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Small reverse transcriptases and gene editing systems comprising such

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9074199B1 (en) * 2013-11-19 2015-07-07 President And Fellows Of Harvard College Mutant Cas9 proteins
WO2017044776A1 (en) * 2015-09-10 2017-03-16 Texas Tech University System Single-guide rna (sgrna) with improved knockout efficiency
US10017760B2 (en) * 2016-06-24 2018-07-10 Inscripta, Inc. Methods for generating barcoded combinatorial libraries
WO2018125964A1 (en) * 2016-12-28 2018-07-05 Ionis Pharmaceuticals, Inc. Modified crispr rna and uses thereof
US9982279B1 (en) * 2017-06-23 2018-05-29 Inscripta, Inc. Nucleic acid-guided nucleases
US11713452B2 (en) * 2017-09-08 2023-08-01 University Of North Texas Health Science Center Engineered CAS9 variants
WO2019090175A1 (en) * 2017-11-02 2019-05-09 Arbor Biotechnologies, Inc. Novel crispr-associated transposon systems and components

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
JP2022546594A5 (https=)
BR112021014123A2 (https=)
JP2022538789A5 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)